F-star, an invoX company
BiotechnologyView the employees at
F-star, an invoX company-
Jayamol Thomas Quality Assurance Associate at Baxter International Inc.
-
Rising Star
Saran Chittoor Vinodkumar Working as a Research Associate in protein sciences team at F-star Therapeutics.-
Cambridge, England, United Kingdom
-
Rising Star
Kirsty Lawrence R&D Cancer Therapeutics Scientist with background in DNA repair and cancer cell biologist-
London, England, United Kingdom
-
Rising Star
Katy Everett Associate Director of Drug Discovery at F-star Therapeutics-
Rising Star
Pamela Payne Accounts Payable Manager at F-star Therapeutics, Inc.-
St. Neots, England, United Kingdom
-
Rising Star
Overview
F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneering bispecific antibodies in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star has four second-generation immunooncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-star’s proprietary antibody discovery platform is protected by an extensive intellectual property estate, with over 500 granted patents and pending patent applications relating to its platform technology and product pipeline. The Company has attracted multiple partnerships with biopharma targeting significant unmet needs across several areas, including oncology, immunology, and CNS.
-